Physician profile
Allison G Hoffman
NPI 1659496586
$663.77
in general payments reported to CMS, 2019-2025
17 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.06 · 2023: $223 · 2024: $269 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $646.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $645.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $106.24 | 2023-2024 | Opzelura |
| Regeneron Healthcare Solutions, INC. | $77.91 | 2019-2025 | Dupixent |
| Amgen INC. | $68.48 | 2023-2025 | Otezla, Otezla |
| Leo Pharma INC. | $61.02 | 2024-2025 | Adbry |
| Arcutis Biotherapeutics, INC. | $45.15 | 2024-2025 | Zoryve |
| Janssen Biotech, INC. | $44.92 | 2023-2024 | Tremfya, Stelara, Simponi |
| Astellas Pharma US INC | $44.34 | 2023-2024 | Xospata |
| E.R. Squibb & Sons, L.L.C. | $41.46 | 2023-2025 | Sotyktu |
| Biofrontera INC. | $37.55 | 2023-2024 | Xepi, Bf-Rhodoled, Ameluz |
| Galderma Laboratories, L.P. | $28.94 | 2024 | |
| Ucb, INC. | $20.95 | 2024 | Bimzelx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.83 | 2024 | Spevigo |
| Dermavant Sciences, INC. | $15.50 | 2023 | Vtama |
| Genzyme Corporation | $14.61 | 2024 | |
| Smith+Nephew, INC. | $13.84 | 2025 | Collagenase Santyl |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $13.64 | 2023 | Taltz |
| Helsinn Therapeutics (U.S.), INC. | $13.39 | 2023 | Valchlor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.